21 |
17 β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
US11045967 |
2005-01-28 |
US07138396B2 |
2006-11-21 |
Timothy J. Guzi; Kamil Paruch; Alan K. Mallams; Jocelyn D. Rivera; Ronald J. Doll; Viyyoor M. Girijavallabhan; Jonathan A. Pachter; Yi-Tsung Liu; Anil K. Saksena |
There are disclosed compounds of the formula (I): prodrugs thereof, or pharmaceutically acceptable salts of the compounds or of said prodrugs which are useful as inhibitors of Type 3 17β-Hydroxysteroid Dehydrogenase. Also disclosed are pharmaceutical compositions containing said compounds and their use for the treatment or prevention of androgen dependent diseases. |
22 |
Pyrazine-2-carboxamide derivatives as mGluR5 antagonists |
JP2007557420 |
2006-03-02 |
JP4774410B2 |
2011-09-14 |
コルツェヴスキ,サビーネ; フィエイラ,エリック; ポーター,リチャード・ヒュー・フィリップ; ヤーシュケ,ゲオルク |
|
23 |
Selective estrogen receptor modulators, including phenylsulfonyl group |
JP2004522648 |
2003-07-16 |
JP4656939B2 |
2011-03-23 |
オーウェン・ブレンダン・ウォレス; キン・チュウ・フォン; コンラッド・ウィルソン・ハメル; ジェフリー・アラン・ドッジ; ジョージ・サル・ルイス; スコット・アラン・ジョーンズ; スコット・アラン・フランク; ティモシー・アラン・シェパード; ロバート・ディーン・ダリー |
|
24 |
Pyrazine-2-carboxamide derivatives as mGluR5 antagonists |
JP2007557420 |
2006-03-02 |
JP2008531630A |
2008-08-14 |
コルツェヴスキ,サビーネ; フィエイラ,エリック; ポーター,リチャード・ヒュー・フィリップ; ヤーシュケ,ゲオルク |
本発明は、代謝調節型グルタミン酸受容体アンタゴニストとして有用な一般式(I)の新規なピラジン−2−カルボキシアミド誘導体:式(I)(式中、R
1 、R
2およびR
3は、明細書および特許請求の範囲で定義されたとおりである)に関する。 |
25 |
PYRAZINE -2-CARBOXAMIDE DERIVATIVES AS mGluR5 ANTAGONISTS |
EP06707356.9 |
2006-03-02 |
EP1858862B1 |
2016-04-20 |
JAESCHKE, Georg; KOLCZEWSKI, Sabine; PORTER, Richard, Hugh, Philip; VIEIRA, Eric |
|
26 |
SELECTIVE ESTROGEN RECEPTOR MODULATORS CONTAINING A PHENYLSULFONYL GROUP |
EP03765254.2 |
2003-07-16 |
EP1530470B1 |
2009-06-10 |
DALLY, Robert, Dean; DODGE, Jeffrey, Alan; FRANK, Scott, Alan; JONES, Scott, Alan; SHEPHERD, Timothy, Alan; WALLACE, Owen, Brendan; FONG, Kin, Chiu; HUMMEL, Conrad, Wilson; LEWIS, Geroge, Sal |
The present invention relates to a selective estrogen receptor modulator of formula I or a pharmaceutical acid addition salt thereof; useful, e.g., for treating endometriosis and/or uterine leiomyoma/leiomyomata. |
27 |
11-BETA HSD1 INHIBITORS |
EP07717205.4 |
2007-02-07 |
EP1981848A2 |
2008-10-22 |
XIANG, Jason Shaoyun; SAIAH, Eddine; TAM, Steve Y.; MCKEW, John C.; CHEN, Lihren; IPEK, Manus; LEE, Katherine; LI, Huan-Qui; LI, Jianchang; LI, Wei; MANSOUR, Tarek Suhayl; SURI, Vipin; VARGAS, Richard; WU, Yuchuan; WAN, Zhao-Kui; LEE, Jinbo; BINNUN, Eva; WILSON, Douglas P. |
This invention relates to inhibiting 11βHSD1. |
28 |
PYRAZINE -2-CARBOXAMIDE DERIVATIVES AS mGluR5 ANTAGONISTS |
EP06707356.9 |
2006-03-02 |
EP1858862A1 |
2007-11-28 |
PORTER, Richard, Hugh, Philip; VIEIRA, Eric; JAESCHKE, Georg; KOLCZEWSKI, Sabine |
The present invention is concerned with novel pyrazine 2-carboxyamide derivatives of the general formula (I) useful as metabotropic glutamate receptor antagonists: formula (I) wherein R1, R2 and R3 are as defined in the description and claims. |
29 |
NOVEL M3 MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS |
EP04813056.1 |
2004-12-03 |
EP1694327A2 |
2006-08-30 |
BUSCH-PETERSEN, Jakob; JIN, Jian; PALOVICH, Michael R.; FU, Wei |
Muscarinic Acetylcholine receptor antagonists and methods of using them are provided. |
30 |
ORGANIC ELECTROLUMINESCENT COMPOUND, AND ORGANIC ELECTROLUMINESCENT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME |
US15509590 |
2015-09-25 |
US20170294590A1 |
2017-10-12 |
Doo-Hyeon Moon; Jeong-Eun Yang; Hee-Ryong Kang; Young-Mook Lim; Ji-Song Jun; Hee-Choon Ahn; Jin-Ri Hong; Su-Hyun Lee; Bitnari Kim; Tae-Jin Lee |
The present disclosure relates to an organic electroluminescent compound, and an organic electroluminescent material and an organic electroluminescent device comprising the same. The organic electroluminescent compound of the present disclosure has excellent color purity, solubility, and thermal stability. By comprising the organic electroluminescent compound and the organic electroluminescent material of the present disclosure, an organic electroluminescent device showing low driving voltage, excellent current and power efficiencies, and significantly improved lifespan can be provided. |
31 |
Synthesis of photovoltaic conjugated polymers |
US14640184 |
2015-03-06 |
US09783634B2 |
2017-10-10 |
Shuangxi Wang; Chenjun Shi; Ruby Chen; Junlian Zhang; Wei Wang; Yue Wu; Hui Huang; Amit Palkar; Ting He |
A method of making a fluorothieno[3,4-b]thiophene derivatives and photovoltaic polymers containing same using 3-bromothiophene-2-carboxylic acid as a starting material. This synthetic route provides an easier synthesis as well as greater yield and a purer product, which produces superior results over the prior art less pure products. The resulting materials can be used in a variety of photovoltaic applications and devices, especially solar cells. |
32 |
SYNTHESIS OF PHOTOVOLTAIC CONJUGATED POLYMERS |
US14640184 |
2015-03-06 |
US20150210800A1 |
2015-07-30 |
Shuangxi Wang; Chenjun Shi; Ruby Chen; Junlian Zhang; Wei Wang; Yue Wu; Hui Huang; Amit Palkar; Ting He |
A method of making a fluorothieno[3,4-b]thiophene derivatives and photovoltaic polymers containing same using 3-bromothiophene-2-carboxylic acid as a starting material. This synthetic route provides an easier synthesis as well as greater yield and a purer product, which produces superior results over the prior art less pure products. The resulting materials can be used in a variety of photovoltaic applications and devices, especially solar cells. |
33 |
Synthesis of photovoltaic conjugated polymers |
US13764919 |
2013-02-12 |
US09006568B2 |
2015-04-14 |
Shuangxi Wang; Chenjun Shi; Ruby Chen; Junlian Zhang; Hui Huang; Yue Wu; Wei Wang; Amit Palkar; Ting He |
A method of making a fluorothieno[3,4-b]thiophene derivatives and photovoltaic polymers containing same using 3-bromothiophene-2-carboxylic acid as a starting material. This synthetic route provides an easier synthesis as well as greater yield and a purer product, which produces superior results over the prior art less pure products. The resulting materials can be used in a variety of photovoltaic applications and devices, especially solar cells. |
34 |
ARYLOSULFONAMIDES FOR THE TREATMENT OF CNS DISEASES |
US14338704 |
2014-07-23 |
US20140336200A1 |
2014-11-13 |
Marcin KOŁACZKOWSKI; Piotr KOWALSKI; Jolanta Jaskowska; Monika MARCINKOWSKA; Katarzyna MITKA; Adam BUCKI; Anna WESOŁOWSKA; Maciej PAWŁOWSKI |
Arylsulphonamide derivatives of formula (I) and pharmaceutically acceptable salts thereof. The compounds may be useful for the treatment and/or prevention of disorders of the central nervous system. |
35 |
PROCESS FOR THE PREPARATION OF AN HIV INTEGRASE INHIBITOR |
US14045033 |
2013-10-03 |
US20140094610A1 |
2014-04-03 |
Wenjie LI; Philomen DECROOS; Keith R. FANDRICK; Joe Ju GAO; Nizar HADDAD; Zhi-Hui LU; Bo QU; Sonia RODRIGUEZ; Chris H. SENANAYAKE; Yongda ZHANG; Wenjun TANG |
The present invention is directed to an improved process for the preparation of Compounds of Formula (I) or salts thereof which are useful in the treatment of HIV infection. In particular, the present invention is directed to an improved process for the preparation of (2S)-2-tert-butoxy-2-(4-(2,3-dihydropyrano[4,3,2-de]quinolin-7-yl)-2-methylquinolin-3-yl)acetic acid or salt thereof which is useful in the treatment of HIV infection. |
36 |
SYNTHESIS OF PHOTOVOLTAIC CONJUGATED POLYMERS |
US13764919 |
2013-02-12 |
US20130214213A1 |
2013-08-22 |
Shuangxi Wang; Chenjun Shi; Ruby Chen; Junlian Zhang; Hui Huang; Yue Wu; Wei Wang; Amit Palkar; Ting He |
A method of making a fluorothieno[3,4-b]thiophene derivatives and photovoltaic polymers containing same using 3-bromothiophene-2-carboxylic acid as a starting material. This synthetic route provides an easier synthesis as well as greater yield and a purer product, which produces superior results over the prior art less pure products. The resulting materials can be used in a variety of photovoltaic applications and devices, especially solar cells. |
37 |
Actinic-Ray- or Radiation-Sensitive Resin Composition, Compound and Method of Forming Pattern Using the Composition |
US13485793 |
2012-05-31 |
US20120237874A1 |
2012-09-20 |
Shuhei Yamaguchi; Akinori Shibuya |
According to one embodiment, an actinic-ray- or radiation-sensitive resin composition includes any of the compounds (A) of general formula (I) below that when exposed to actinic rays or radiation, generates an acid and a resin (B) whose rate of dissolution into an alkali developer is increased by the action of an acid. (The characters used in general formula (I) have the meanings mentioned in the description.) |
38 |
PHOTORESIST COMPOSITION |
US13025876 |
2011-02-11 |
US20110200935A1 |
2011-08-18 |
Tatsuro MASUYAMA; Satoshi YAMAGUCHI |
The present invention provides a photoresist composition having a sulfonium salt comprising an anion represented by the formula (IA): wherein R1 and R2 independently represent a hydrogen atom, a C1-C12 aliphatic hydrocarbon group, a C3-C20 saturated cyclic hydrocarbon group, a C6-C20 aromatic hydrocarbon group or a C7-C21 aralkyl group, and the aliphatic hydrocarbon group, the saturated cyclic hydrocarbon group, the aromatic hydrocarbon group and the aralkyl group can have one or more substituents selected from the group consisting of a hydroxyl group, a cyano group, a fluorine atom, a trifluoromethyl group and a nitro group, and one or more —CH2— in the aliphatic hydrocarbon group can be replaced by —O— or —CO—, or R1 and R2 are bonded each other to form a C4-C20 nitrogen-containing ring together with the nitrogen atom to which they are bonded, an acrylic resin having an acid-labile group and being insoluble or poorly soluble in an aqueous alkali solution but becoming soluble in an aqueous alkali solution by the action of an acid, and an acid generator. |
39 |
Pyrazine-2-carboxyamide derivatives |
US12470554 |
2009-05-22 |
US07947685B2 |
2011-05-24 |
Georg Jaeschke; Sabine Kolczewski; Richard Hugh Philip Porter; Eric Vieira |
The present invention is concerned with novel pyrazine 2-carboxyamide derivatives of formula (I) wherein R1, R2 and R3 are as defined in the specification. These compounds are useful for the treatment of CNS disorders. |
40 |
ORGANIC DYE USED IN DYE-SENSITIZED SOLAR CELL |
US12958609 |
2010-12-02 |
US20110077408A1 |
2011-03-31 |
Marappan Velusamy; Koilpitchai R. Justin Thomas; Jiann T'suen Lin; Kuo-Chuan Ho; Ying-Chan Hsu |
An organic dye used in a dye-sensitized solar cell is described, having general formula (1): D-Sp1-Ch-Sp2-Acc-Y (1) wherein the groups D, Ch, Acc and Y are conjugate with each other, the group D is a donor group, the group Ch is a chromophore rendering low HOMO-LUMO gap or a polyaromatic chromophore, the group Acc is an acceptor group, the group Y is an anchoring group, and each of Sp1 and Sp2 represents a single bond or a spacer group allowing conjugation between the groups D and Ch or between the groups Ch and Acc. |